HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Implementation of a Neonatal Abstinence Syndrome Weaning Protocol: A Multicenter Cohort Study.

AbstractOBJECTIVES:
To evaluate the generalizability of stringent protocol-driven weaning in improving total duration of opioid treatment and length of inpatient hospital stay after treatment of neonatal abstinence syndrome (NAS).
METHODS:
We conducted a retrospective cohort analysis of 981 infants who completed pharmacologic treatment of NAS with methadone or morphine from January 2012 through August 2014. Before July 2013, 3 of 6 neonatology provider groups (representing Ohio's 6 children's hospitals) directed NAS nursery care by using group-specific treatment protocols containing explicit weaning guidelines. In July 2013, a standardized weaning protocol was adopted by all 6 groups. Statistical analysis was performed to identify effects of adoption of the multicenter weaning protocol on total duration of opioid treatment and length of hospital stay at the protocol-adopting sites and at the sites with preexisting protocol-driven weaning.
RESULTS:
After adoption of the multicenter protocol, infants treated by the 3 groups previously without stringent weaning guidelines experienced shorter duration of opioid treatment (23.0 vs 34.0 days, P < .001) and length of inpatient hospital stay (23.7 vs 31.6 days, P < .001). Protocol-adopting sites also experienced a lower rate of adjunctive drug therapy (5% vs 21%, P = .004). Outcomes were sustained by the 3 groups who initially had specific weaning guidelines after multicenter adoption (duration of treatment = 17.0 days and length of hospital stay = 23.3 days).
CONCLUSIONS:
Adoption of a stringent weaning protocol resulted in improved NAS outcomes, demonstrating generalizability of the protocol-driven weaning approach. Opportunity remains for additional protocol refinement.
AuthorsEric S Hall, Scott L Wexelblatt, Moira Crowley, Jennifer L Grow, Lisa R Jasin, Mark A Klebanoff, Richard E McClead, Jareen Meinzen-Derr, Vedagiri K Mohan, Howard Stein, Michele C Walsh, OCHNAS Consortium
JournalPediatrics (Pediatrics) Vol. 136 Issue 4 Pg. e803-10 (Oct 2015) ISSN: 1098-4275 [Electronic] United States
PMID26371196 (Publication Type: Journal Article, Multicenter Study, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 by the American Academy of Pediatrics.
Chemical References
  • Analgesics, Opioid
  • Morphine
  • Methadone
Topics
  • Adult
  • Analgesics, Opioid (administration & dosage, therapeutic use)
  • Clinical Protocols
  • Cohort Studies
  • Female
  • Humans
  • Infant, Newborn
  • Length of Stay
  • Male
  • Methadone (administration & dosage, therapeutic use)
  • Morphine (administration & dosage, therapeutic use)
  • Neonatal Abstinence Syndrome (therapy)
  • Opioid-Related Disorders (therapy)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: